Published in Am J Dig Dis on May 01, 1978
Interim results of a multicenter international comparison of misoprostol and cimetidine in the treatment of out-patients with benign gastric ulcers. Dig Dis Sci (1985) 0.98
Misoprostol in the treatment of duodenal ulcer. A multicenter double-blind placebo-controlled study. Dig Dis Sci (1985) 0.87
Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study. Dig Dis Sci (1985) 0.86
Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1. Dig Dis Sci (1985) 0.85
Effects of misoprostol on gastric acid and mucus secretion in man. Dig Dis Sci (1986) 0.84
Misoprostol versus antacid titration for preventing stress ulcers in postoperative surgical ICU patients. Ann Surg (1989) 0.81
Gastric mucosal damage in sepsis--effects of pretreatment with a synthetic prostaglandin E1 analogue. Gut (1985) 0.80
Effect of glucagon and pentagastrin on gastric mucosal potential difference in man. Gut (1978) 0.80
Therapeutic aspects of prostaglandins in the treatment of peptic ulcer disease. Dig Dis Sci (1986) 0.80
Prostaglandin E1 (misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healing. Dig Dis Sci (1986) 0.79
Gastrointestinal cytoprotective effects of misoprostol. Clinical efficacy overview. Dig Dis Sci (1985) 0.78
Effect of misoprostol, an antiulcer prostaglandin, on serum gastrin in patients with duodenal ulcer. Dig Dis Sci (1986) 0.77
Gastric mucosal blood flow in misoprostol pretreated aspirin-induced ulceration. Ann Surg (1988) 0.77
Effects of a prostaglandin E1 derivative, SC-29333, and aspirin on gastric ionic fluxes and potential difference in dogs. J Pharmacol Exp Ther (1979) 1.08
Loperamide binding to opiate receptor sites of brain and myenteric plexus. J Pharmacol Exp Ther (1976) 1.06
Chemistry and synthetic development of misoprostol. Dig Dis Sci (1985) 1.05
SC-29333: a potent inhibitor of canin gastric secretion. Am J Dig Dis (1976) 1.04
Effect of SC-29333, an inhibitor of gastric secretion, on canine gastric mucosal blood flow and serum gastrin levels. Arch Int Pharmacodyn Ther (1978) 0.87
The pharmacology of SC-27166: a novel antidiarrheal agent. J Pharmacol Exp Ther (1977) 0.87
Misoprostol in the treatment of duodenal ulcer. A multicenter double-blind placebo-controlled study. Dig Dis Sci (1985) 0.87
Comparative gastric antisecretory and antiulcer effects of prostaglandin E1 and its methyl ester in animals. Prostaglandins (1975) 0.86
3,3-Diphenyl-3-(2-alkyl-1,3,4-oxadiazol-5-yl)propylcycloalkylamines, a novel series of antidiarrheal agents. J Med Chem (1976) 0.86
Inhibition of intestinal secretion in the dog: a new approach for the management of diarrheal states. J Pharmacol Exp Ther (1981) 0.85
Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1. Dig Dis Sci (1985) 0.85
Comparative cytoprotective effects against alcohol insult. Misoprostol versus cimetidine. Dig Dis Sci (1986) 0.84
Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates. Am J Pathol (1995) 0.83
Systemic treatment with epidermal growth factor in pigs induces ductal proliferations in the pancreas. Gastroenterology (1997) 0.82
Idiopathic esophageal ulceration in acquired immunodeficiency syndrome: successful treatment with misoprostol and viscous lidocaine. Am J Gastroenterol (1998) 0.82
Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man. Dig Dis Sci (1988) 0.81
Is peptic ulcer a prostaglandin deficiency disease? Hum Pathol (1986) 0.81
Effects of E prostaglandins, diphenoxylate and morphine on intestinal motility in vivo. Eur J Pharmacol (1975) 0.80
Impedance planimetric characterization of the distal oesophagus in the Goettingen minipig. J Biomech (1996) 0.80
Misoprostol but not antacid prevents endotoxin-induced gastric mucosal injury: role of tumor necrosis factor-alpha. Dig Dis Sci (1991) 0.79
Gastrointestinal cytoprotective effects of misoprostol. Clinical efficacy overview. Dig Dis Sci (1985) 0.78
Biomechanical properties of the oesophagus damaged by endoscopic sclerotherapy. An impedance planimetric study in minipigs. Scand J Gastroenterol (1994) 0.78
Systemic treatment with recombinant human epidermal growth factor accelerates healing of sclerotherapy-induced esophageal ulcers and prevents esophageal stricture formations in pigs. Dig Dis Sci (1994) 0.78
Tissue distribution of 131I-labelled epidermal growth factor in the pig visualized by dynamic scintigraphy. J Endocrinol (1995) 0.78
Effect of misoprostol, an antiulcer prostaglandin, on serum gastrin in patients with duodenal ulcer. Dig Dis Sci (1986) 0.77
Gastric antisecretory actions of (15S)-15-methyl prostaglandin E2 methyl ester and natural prostaglandin E2 in rhesus monkeys. Prostaglandins (1976) 0.77
Chronic systemic treatment with epidermal growth factor induces hypergastrinaemia in Goettingen minipigs. Scand J Gastroenterol (1995) 0.77
Gastrointestinal toxicity of over-the-counter analgesics. Am J Gastroenterol (1998) 0.77
Refractory peptic ulcers. J Assoc Acad Minor Phys (1992) 0.77
Misoprostol prevents damage to the gastric mucosa by stabilizing the mast cells. Prostaglandins (1987) 0.77
Chronic treatment with epidermal growth factor causes esophageal epithelial hyperplasia in pigs and rats. Dig Dis Sci (1995) 0.76
Cytoprotection by a synthetic prostaglandin against ethanol-induced gastric mucosal damage. A double-blind endoscopic study in human subjects. Gastrointest Endosc (1986) 0.76
Antidiarrheal and central nervous system activities of SC-27166 (2-[3 - 5 - methyl - 1, 3, 4 - oxadiazol - 2 - yl) - 3, 3 - diphenylpropyl] - 2 - azabicyclo [2.2.2]octane), a new antidiarrheal agent, resulting from binding to opiate receptor sites of brain and myenteric plexus. J Pharmacol Exp Ther (1977) 0.76
Epidermal growth factor attenuates the sclerotherapy-induced biomechanical properties of the oesophagus. An experimental study in minipigs. Scand J Gastroenterol (1995) 0.76
Synthesis and gastric antisecretory properties of 15-deoxy-16-hydroxyprostaglandin E analogues. J Med Chem (1977) 0.75
Misoprostol attenuates aspirin-induced changes in potential difference and associated damage in canine gastric mucosa. Clin Invest Med (1987) 0.75
Omega-3 fatty acids and bowel cancer. Gastroenterology (1993) 0.75
Prostaglandins, NSAIDS, and GI mucosal integrity: can we identify patients at risk of NSAID-induced gastric injury? Am J Gastroenterol (1996) 0.75
Highlights of the 14th Annual Scientific Meeting of the Association for Academic Minority Physicians, 2000. J Assoc Acad Minor Phys (2001) 0.75
Effects of 7-oxa-13-prostynoic acid (7-OPyA) and prostaglandin E1 methyl ester on canine gastric secretion. Prostaglandins (1977) 0.75
Influence of the position of the side chain hydroxy group on the gastric antisecretory and antiulcer actions of E1 prostaglandin analogs. Prostaglandins (1975) 0.75
Chronic administration of epidermal growth factor to pigs induces growth, especially of the urinary tract with accumulation of epithelial glycoconjugates. Lab Invest (1995) 0.75
Synthesis and biological evaluation of omega-homologues of prostaglandin E1. J Med Chem (1976) 0.75
Synergistic actions of propantheline bromide with cimetidine and thiopropazate hydrochloride in the prevention of stress ulcer formation in rats. J Pharmacol Exp Ther (1979) 0.75
Future treatment of peptic ulcer: is there room for anti-infective drugs? J Physiol Pharmacol (1993) 0.75
Gastric antiulcer and antisecretory effects of carbenoxolone, aldosterone and desoxycorticosterone in rats. Arch Int Pharmacodyn Ther (1979) 0.75
Idiopathic esophageal ulceration in patients infected with human immunodeficiency virus. J Assoc Acad Minor Phys (1996) 0.75
Effects of tolcapone, a catechol-O-methyltransferase inhibitor, and Sinemet on intestinal electrolyte and fluid transport in conscious dogs. Dig Dis Sci (1998) 0.75
Chronic systemic treatment with epidermal growth factor induces smooth muscle cell hyperplasia and hypertrophy in the urinary tract of mature Goettingen minipigs. Br J Urol (1997) 0.75
Novel, low cost approach to digitizing tablet hardness values. J Pharm Sci (1975) 0.75
Gastric antisecretory effects of propantheline bromide and metiamide in rhesus monkeys. Arch Int Pharmacodyn Ther (1978) 0.75
Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury. Int J Clin Pharmacol Res (1989) 0.75
The effect of epidermal growth factor on circulating levels of IGF and IGF-binding proteins in adult Goettingen minipigs. J Endocrinol (1996) 0.75
Nonsteroidal anti-inflammatory drugs and acute upper gastrointestinal bleeding: a prospective study. J Assoc Acad Minor Phys (1991) 0.75
Postnatal development of the electrocortical activity in the golden hamster (Mesocricetus auratus). Dev Psychobiol (1973) 0.75
Systemic treatment with epidermal growth factor induces anaemia in Goettingen minipigs. Clin Sci (Lond) (1995) 0.75
Instrumentation of a tablet breaking-strength tester. J Pharm Sci (1984) 0.75
Gastric antisecretory effects of E prostaglandins in Rhesus monkeys. Am J Dig Dis (1976) 0.75
The role of nutrition in the development of evoked cortical responses in rat. Brain Res (1967) 0.75
Preventive effects of recombinant human epidermal growth factor on the oesophageal epithelium in pigs subjected to sclerotherapy. Eur J Gastroenterol Hepatol (1995) 0.75
Update on acid-peptic disorders. J Assoc Acad Minor Phys (1992) 0.75
Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs. J Assoc Acad Minor Phys (1992) 0.75
Ureteric growth in a Goettingen minipig induced by epidermal growth factor. A case report. Scand J Urol Nephrol Suppl (1995) 0.75
Naloxone reversal of drug-induced diarrhea in mice. Arch Int Pharmacodyn Ther (1979) 0.75
Design and hardware selection of a microcomputer based system for the recording of animal observation data. Drug Inf J (1978) 0.75
The effects of aging on schizophrenic and mentally defective patients: visual, auditory, and grip strength measurements. J Gerontol (1971) 0.75
Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage. J Rheumatol Suppl (1990) 0.75
Effect of oral and intravenous propantheline bromide on pentagastrin-stimulated canine gastric secretion. Arch Int Pharmacodyn Ther (1978) 0.75
Antiulcer drugs and gastric mucosal integrity. Effects of misoprostol, 16,16-dimethyl PGE2, and cimetidine on hemodynamics and metabolic rate in canine gastric mucosa. Dig Dis Sci (1992) 0.75
Canine gastrointestinal motility effects of prostaglandin F2 alpha in vivo. Arch Int Pharmacodyn Ther (1979) 0.75
Is cytoprotection by misoprostol against ethanol-induced gastric mucosal injury in man mediated by somatostatin? Prostaglandins (1987) 0.75
Synthesis and gastric antisecretory properties of 4,5-unsaturated derivatives of 15-deoxy-16-hydroxy-16-methylprostaglandin E1. J Med Chem (1983) 0.75